4ork

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4ork]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ORK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ORK FirstGlance]. <br>
<table><tr><td colspan='2'>[[4ork]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ORK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ORK FirstGlance]. <br>
-
</td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GDP:GUANOSINE-5-DIPHOSPHATE'>GDP</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene><br>
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GDP:GUANOSINE-5-DIPHOSPHATE'>GDP</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr>
-
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ork FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ork OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ork RCSB], [http://www.ebi.ac.uk/pdbsum/4ork PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ork FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ork OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4ork RCSB], [http://www.ebi.ac.uk/pdbsum/4ork PDBsum]</span></td></tr>
-
<table>
+
</table>
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/AACA_STAAU AACA_STAAU]] Resistance to gentamicin, tobramycin, and kanamycin. Tobramycin and kanamycin resistance is due to the ACC activity, specified by N-terminal region, and the gentamicin resistance is due to the APH activity encoded by the C-terminal region of the protein.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 18: Line 20:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Bhattacharya, M.]]
+
[[Category: Bhattacharya, M]]
-
[[Category: Frase, H.]]
+
[[Category: Frase, H]]
-
[[Category: Smith, C A.]]
+
[[Category: Smith, C A]]
-
[[Category: Toth, M.]]
+
[[Category: Toth, M]]
-
[[Category: Vakulenko, S B.]]
+
[[Category: Vakulenko, S B]]
[[Category: Aminoglycosides and gtp]]
[[Category: Aminoglycosides and gtp]]
[[Category: Antibiotic resistance]]
[[Category: Antibiotic resistance]]
[[Category: Kinase]]
[[Category: Kinase]]
[[Category: Transferase]]
[[Category: Transferase]]

Revision as of 05:22, 25 December 2014

Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2)-Ia

4ork, resolution 2.30Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools